Eli Lil­ly says its po­ten­tial gene ther­a­py 're­stored hear­ing' in 11-year-old boy

An 11-year-old boy who re­ceived Eli Lil­ly’s ex­per­i­men­tal gene ther­a­py for hear­ing loss last Oc­to­ber showed signs of re­stored hear­ing 30 days af­ter treat­ment, the phar­ma gi­ant an­nounced on Tues­day.

The ther­a­py, dubbed AK-OTOF, is de­signed to de­liv­er a func­tion­al copy of a gene called otofer­lin. With­out otofer­lin, au­di­to­ry sig­nals re­ceived by the ear aren’t trans­mit­ted to the brain. Lil­ly es­ti­mates that 200,000 peo­ple world­wide ex­pe­ri­ence hear­ing loss caused by mu­ta­tions to otofer­lin.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER